WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012112426) ARGININE VASOPRESSIN RETARGETED CLOSTRIDIAL ENDOPEPTIDASES FOR USE IN TREATING BENIGN PROSTATIC HYPERPLASIA
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/112426    International Application No.:    PCT/US2012/024832
Publication Date: 23.08.2012 International Filing Date: 13.02.2012
IPC:
A61K 38/48 (2006.01), A61P 13/08 (2006.01), A61K 47/48 (2006.01)
Applicants: ALLERGAN, INC. [US/US]; 2525 Dupont Drive Irvine, California 92612 (US) (For All Designated States Except US).
JACKY, Birgitte P.S. [DK/US]; (US) (For US Only).
GARAY, Patton E. [US/US]; (US) (For US Only).
MOLINA, Yanira [US/US]; (US) (For US Only).
FRANCIS, Joseph [CA/US]; (US) (For US Only).
STEWARD, Lance E. [US/US]; (US) (For US Only).
GHANSHANI, Sanjiv [US/US]; (US) (For US Only).
HUNT, Terrence J. [US/US]; (US) (For US Only).
AOKI, K. Roger [US/US]; (US) (For US Only).
FERNANDEZ-SALAS, Ester [US/US]; (US) (For US Only)
Inventors: JACKY, Birgitte P.S.; (US).
GARAY, Patton E.; (US).
MOLINA, Yanira; (US).
FRANCIS, Joseph; (US).
STEWARD, Lance E.; (US).
GHANSHANI, Sanjiv; (US).
HUNT, Terrence J.; (US).
AOKI, K. Roger; (US).
FERNANDEZ-SALAS, Ester; (US)
Agent: ABEL, Kenton B.; Allergan, Inc. 2525 Dupont Drive Irvine, California 92612 (US)
Priority Data:
61/442,649 14.02.2011 US
Title (EN) ARGININE VASOPRESSIN RETARGETED CLOSTRIDIAL ENDOPEPTIDASES FOR USE IN TREATING BENIGN PROSTATIC HYPERPLASIA
(FR) ENDOPEPTIDASES CLOSTRIDIENNES RECIBLÉES SUR ARGININE VASOPRESSINE POUR UNE UTILISATION DANS LE TRAITEMENT DE L'HYPERPLASIE PROSTATIQUE BÉNIGNE
Abstract: front page image
(EN)The present specification discloses TVEMPs, in particular arginine vasopressin retargeted clostridial endopeptidases, for use in the treatment of benign prostatic hyperplasia.
(FR)La présente invention concerne des TVEMP, notamment des endopeptidases clostridiennes reciblées sur arginine vasopressine pour une utilisation dans le traitement de l'hyperplasie prostatique bénigne.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)